Sequana Medical Résultats passés
Passé contrôle des critères 0/6
Sequana Medical's earnings have been declining at an average annual rate of -15.8%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 10% per year.
Informations clés
-15.8%
Taux de croissance des bénéfices
2.9%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | 12.3% |
Taux de croissance des recettes | -10.0% |
Rendement des fonds propres | n/a |
Marge nette | -6,269.8% |
Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Ventilation des recettes et des dépenses
Comment Sequana Medical gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 0 | -27 | 21 | 3 |
31 Mar 24 | 1 | -30 | 24 | 3 |
31 Dec 23 | 1 | -33 | 26 | 4 |
30 Sep 23 | 1 | -32 | 27 | 4 |
30 Jun 23 | 1 | -32 | 27 | 4 |
31 Mar 23 | 1 | -32 | 26 | 4 |
31 Dec 22 | 1 | -31 | 25 | 4 |
30 Sep 22 | 1 | -29 | 24 | 4 |
30 Jun 22 | 1 | -27 | 23 | 3 |
31 Mar 22 | 1 | -25 | 22 | 3 |
31 Dec 21 | 0 | -24 | 21 | 3 |
30 Sep 21 | 0 | -23 | 19 | 3 |
30 Jun 21 | 0 | -21 | 18 | 3 |
31 Mar 21 | 1 | -20 | 17 | 2 |
31 Dec 20 | 1 | -19 | 17 | 2 |
30 Sep 20 | 1 | -18 | 16 | 2 |
30 Jun 20 | 1 | -17 | 16 | 1 |
31 Mar 20 | 1 | -16 | 15 | 1 |
31 Dec 19 | 1 | -15 | 14 | 1 |
30 Sep 19 | 1 | -16 | 12 | 2 |
30 Jun 19 | 1 | -16 | 12 | 2 |
31 Mar 19 | 1 | -15 | 11 | 2 |
31 Dec 18 | 1 | -14 | 10 | 2 |
30 Sep 18 | 1 | -10 | 9 | 1 |
31 Dec 17 | 1 | -8 | 8 | 1 |
31 Dec 16 | 1 | -14 | 14 | 1 |
31 Dec 15 | 2 | -12 | 12 | 1 |
Des revenus de qualité: SEQUA is currently unprofitable.
Augmentation de la marge bénéficiaire: SEQUA is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: SEQUA is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.
Accélération de la croissance: Unable to compare SEQUA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: SEQUA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).
Rendement des fonds propres
ROE élevé: SEQUA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.